| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 59,465 | 50,848 | 31,808 | 69,398 | | Cost of Revenue | 61,240 | 59,133 | 43,600 | 78,292 | | | Gross Profit | (1,775) | (8,285) | (11,792) | (8,894) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,602 | 6,497 | 6,819 | 7,996 | | Non Recurring | 855 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,232) | (14,782) | (18,611) | (16,890) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 86 | 209 | 633 | 524 | | Earnings Before Interest And Taxes | (9,146) | (14,573) | (17,978) | (16,366) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (9,146) | (14,573) | (17,978) | (16,366) | | Income Tax Expense | 41,090 | (6,020) | (7,597) | (6,770) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (50,236) | (8,553) | (10,381) | (9,596) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (50,236) | (8,553) | (10,381) | (9,596) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($50,236) | ($8,553) | ($10,381) | ($9,596) |
|
0.51% Nasdaq 
Income Statement
